SRRK
SRRK
NASDAQ · Biotechnology

Scholar Rock Holding Corp

$49.19
+1.86 (+3.93%)
Analyst Consensus
Strong Buy
24
Analysts
High
Coverage
Buy 23 96%
Hold 1 4%
Sell 0 0%
Price Target
Analyst Price Target +44.9% upside
Low Target $54.07
Average Target $71.29
High Target $91.55
Current Price $49.19
Current
$49.19
Target
$71.29
$54.07 $71.29 avg $91.55
Scenario Analysis
Bear Case
$54.07
9.9%
Low target
Base Case
$71.29
+44.9%
Avg target
Bull Case
$91.55
+86.1%
High target
Risk/Reward
8.7x
Highly favorable
Price in Context
52-Week High
$52.19
-5.7% from high
52-Week Low
$27.07
+81.7% from low
50-Day SMA
$45.16
+8.9% vs SMA
200-Day SMA
$36.91
+33.3% vs SMA
RSI (14)
59.5
Neutral
Target vs 52W High
$71.29
+36.6% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 40 78% $257.58 +10.2%
AMGN
Amgen Inc
Hold 44 50% $190.87 -45.0%
GILD
Gilead Sciences Inc
Strong Buy 39 82% $362.68 +188.2%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 40 83% $438.34 -6.6%
REGN
Regeneron Pharmaceuticals
Buy 38 71% $76.80 -87.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 37 76% $102.31 -64.5%
RVMD
Revolution Medicines Inc
Strong Buy 27 96% $114.11 -31.2%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -39.1%